Search for: "KING PHARMA V EON LABS"
Results 1 - 8
of 8
Sorted by Relevance
|
Sort by Date
23 Jan 2009, 7:49 am
King Pharmaceuticals, Inc et al v. [read post]
23 Feb 2009, 9:59 pm
Eon Labs, Inc., the U.S. [read post]
18 Aug 2010, 12:19 am
Eon Labs, Inc. [read post]
10 Aug 2010, 8:44 pm
Highlights this week included: CAFC: Genus-species; doctrine of equivalents; and patentable subject matter: Intervet v Merial Limited (Patently-O) (Holman’s Biotech IP Blog) (IP Spotlight) (IPBiz) (Patent Docs) Angiomax (Bivalirudin) – US: The Medicines Company prevails in patent term extension dispute; USPTO acts quickly to comply with court order (Patent Docs) (Patent Docs) (IPBiz) Skelaxin (Metaxalone) – US: CAFC: Ignoring non-patentable elements while judging… [read post]
23 Jan 2009, 12:00 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
30 Jan 2009, 9:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: AIPLA urges Federal Circuit not to proscribe patents for biomedical diagnostic tools: Prometheus v Mayo (Inventive Step) (Hal Wegner) (Patently-O) (Holman's Biotech IP Blog) Lovenox (Enoxaparin) – US: Aventis files for certiorari: challenging Federal Circuit’s low standard for intent to deceive in… [read post]
2 Apr 2007, 9:52 pm
Barr Skelaxin: King v. [read post]
14 Nov 2016, 9:16 am
Watson Labs raises a core substantive patent issue – does the on sale bar apply to secret sales? [read post]
